medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2018, Number 4

<< Back Next >>

Ann Hepatol 2018; 17 (4)

Pattern of Vascular Involvement in Egyptian Patients with Budd-Chiari Syndrome: Relation to Etiology and Impact on Clinical Presentation

Sakr MA, Abdelhakam SM, Dabbous HM, Abdelmoaty AS, Ebada HE, Al-Banna WM, Ghazy MS, Aboelmaaty ME, Eldorry AK

Language: English
References: 24
Page: 638-644
PDF size: 148.66 Kb.


ABSTRACT

Introduction and aim. Budd-Chiari syndrome (BCS) is caused by hepatic venous outflow obstruction. This work aims to analyze the pattern of vascular involvement in Egyptian patients with BCS, demonstrates its relation to etiology and shows its impact on clinical presentation. Material and methods. The current retrospective study was conducted at The Tropical Medicine Department, Ain Shams University on one hundred Egyptian patients with confirmed diagnosis of primary BCS who were presented to the Budd-Chiari Study Group (BCSG) from April 2014 to May 2016 by collecting clinical, laboratory and radiological data from their medical records. Results. Isolated hepatic vein occlusion (HVO) was the most common pattern of vascular involvement (43%), followed by combined HVO and inferior vena cava (IVC) compression by enlarged caudate lobe (32%), then combined HVO and IVC stenosis/webs (21%), and lastly isolated IVC occlusion (4%). Ascites was more significantly encountered in BCS patients with HVO than in those with isolated inferior vena cava (IVC) occlusion and patent HVs (P = 0.005). Abdominal pain was significantly encountered in patients with occluded three major HVs (P = 0.044). Behcet’s disease was significantly detected in isolated IVC occlusion. Protein C deficiency was significantly detected in patients with combined HVO and IVC compression. Conclusion. Isolated HVs occlusion was the most common pattern of vascular involvement in Egyptian patients with primary BCS. Vascular pattern of involvement affected the clinical presentation and was related to the underlying thrombophilia in those patients.


REFERENCES

  1. Valla DC. Primary Budd-Chiari syndrome. J Hepatol 2009; 50: 195-203.

  2. Aydinti M, Bayraktar Y. Budd-Chiari syndrome: Etiology, Pathogenesis, and Diagnosis. World J Gastroenterol 2007; 13: 2683-96.

  3. Roy PK. Budd-Chiari syndrome. 2006; (http://www. emedicine.com/med/topic2694.htm).

  4. Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin. Liver Dis 2002; 22: 5-14.

  5. Kamath PS. Budd-Chiari syndrome: Radiologic Findings. Liver Transplantation 2006; 12: 21-2.

  6. Ludwig J, Hashimoto E, McGill D.B, van Heerden JA. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd– Chiari syndrome. Mayo Clin Proc 1990; 65: 51-5.

  7. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003; 38: 364-71.

  8. Zhang, Xiao-ming, Li, Qing-le. Etiology, treatment, and classification of Budd-Chiari syndrome. Chinese Medical Journal 2007; 120: 159-61.

  9. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009; 49: 1729-64.

  10. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 2003; 38: 793-803.

  11. McDermott WV, Ridker PM. The Budd-Chiari syndrome and hepatic veno-occlusive disease. Recognition and treatment. Arch Surg 1990; 125: 525-7.

  12. Shin N, Kim YH, Xu H, Shi H, Zhang Q, Pons JP, Kim D, et al. Redefining Budd-Chiari syndrome; A systematic review. World J Hepatol 2016; 8: 691-702.

  13. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 2003; 38: 793-803.

  14. McDermott WV, Ridker PM. The Budd-Chiari syndrome and hepatic veno-occlusive disease. Recognition and treatment. Arch Surg 1990; 125: 525-7.

  15. Darwish MS, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009; 151: 167-75.

  16. Zhou P, Ren J, Han X, Wu G, Zhang W, Ding P, BI Y, et al. Initial imaging analysis of Budd-Chiari syndrome in Henan province of China: most cases have combined inferior vena cava and hepatic veins involvement. PLoS One 2014; 9: e85135.

  17. Sakr M, Barakat E, Abdelhakam S, Dabbous H, Yousuf S, Shaker M, Eldorry A. Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study. World J Gastroenterol 2011; 17: 4704-10.

  18. Eapen CE, Mammen T, Moses V, Shyamkumar NK. Changing profile of Budd-Chiari syndrome in India. Indian J Gastroenterol 2007; 26: 77-81.

  19. Eldorry A, Barakat E, Abdella H, Abdelhakam S, Shaker M, Hamed A, Sakr M. Outcome of non-surgical hepatic decompression procedures in Egyptian patients with Budd-Chiari. World J Gastroenterol 2011; 17: 906-13.

  20. Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary Thrombophilia as a Cause of Budd-Chiari Syndrome: A Study from Western India. Hepatology 2001; 34: 666-70.

  21. Menon KV, Sha V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004; 350: 578-85.

  22. Seijo S, Plessier A, Hoekstra J, Dell’Era A, Mandair D, Rifai K, Trebicka J, et al. Good long term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 2013; 57: 1962-8.

  23. Cheng D, Xu H, Lu ZJ, Hua R, Qiu H, Du H, Xu X, et al. Clinical features and etiology of Budd-Chiari syndrome in Chinese patients: a single-center study. J Gastroenterol Hepatol 2013; 28: 1061-7.

  24. Qi X, Wu F, Ren W, He C, Yin Z, Niu J, Bai M, et al. Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature. Thromb Haemost 2013; 109: 878-84.




2020     |     www.medigraphic.com